Your browser doesn't support javascript.
loading
TRAPEZE: a randomised controlled trial of the clinical effectiveness and cost-effectiveness of chemotherapy with zoledronic acid, strontium-89, or both, in men with bony metastatic castration-refractory prostate cancer.
James, Nicholas; Pirrie, Sarah; Pope, Ann; Barton, Darren; Andronis, Lazaros; Goranitis, Ilias; Collins, Stuart; McLaren, Duncan; O'Sullivan, Joe; Parker, Chris; Porfiri, Emilio; Staffurth, John; Stanley, Andrew; Wylie, James; Beesley, Sharon; Birtle, Alison; Brown, Janet; Chakraborti, Prabir; Russell, Martin; Billingham, Lucinda.
Afiliação
  • James N; Department of Oncology, University Hospital Birmingham NHS Foundation Trust, Birmingham, UK.
  • Pirrie S; Cancer Research Unit, University of Warwick, Coventry, UK.
  • Pope A; Cancer Research UK Clinical Trials Unit, University of Birmingham, Birmingham, UK.
  • Barton D; Cancer Research UK Clinical Trials Unit, University of Birmingham, Birmingham, UK.
  • Andronis L; Cancer Research UK Clinical Trials Unit, University of Birmingham, Birmingham, UK.
  • Goranitis I; Health Economics Unit, University of Birmingham, Birmingham, UK.
  • Collins S; Health Economics Unit, University of Birmingham, Birmingham, UK.
  • McLaren D; Cancer Research UK Clinical Trials Unit, University of Birmingham, Birmingham, UK.
  • O'Sullivan J; Edinburgh Cancer Centre, Western General Hospital, Edinburgh, UK.
  • Parker C; Department of Oncology, Belfast City Hospital, Belfast, UK.
  • Porfiri E; Department of Oncology, Royal Marsden Hospital, Sutton, UK.
  • Staffurth J; Department of Oncology, University Hospital Birmingham NHS Foundation Trust, Birmingham, UK.
  • Stanley A; Institute of Cancer and Genetics, Cardiff University, Cardiff, UK.
  • Wylie J; Velindre Cancer Centre, Cardiff, UK.
  • Beesley S; Pharmacy Department, City Hospital, Birmingham, UK.
  • Birtle A; Department of Oncology, The Christie Hospital, Manchester, UK.
  • Brown J; Kent Oncology Centre, Maidstone Hospital, Kent, UK.
  • Chakraborti P; Rosemere Cancer Centre, Royal Preston Hospital, Preston, UK.
  • Russell M; Department of Oncology, St James' University Hospital, Leeds, UK.
  • Billingham L; Department of Oncology, Royal Derby Hospital, Derby, UK.
Health Technol Assess ; 20(53): 1-288, 2016 07.
Article em En | MEDLINE | ID: mdl-27434595
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Radioisótopos de Estrôncio / Neoplasias Ósseas / Difosfonatos / Conservadores da Densidade Óssea / Neoplasias de Próstata Resistentes à Castração / Imidazóis Tipo de estudo: Clinical_trials / Health_economic_evaluation / Health_technology_assessment / Prognostic_studies Limite: Aged / Humans / Male / Middle aged Idioma: En Ano de publicação: 2016 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Radioisótopos de Estrôncio / Neoplasias Ósseas / Difosfonatos / Conservadores da Densidade Óssea / Neoplasias de Próstata Resistentes à Castração / Imidazóis Tipo de estudo: Clinical_trials / Health_economic_evaluation / Health_technology_assessment / Prognostic_studies Limite: Aged / Humans / Male / Middle aged Idioma: En Ano de publicação: 2016 Tipo de documento: Article